Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Development of a Multidimensional Additive Points System for Determining Access to Rheumatology Services

White, Douglas FRACP*†; Solanki, Kamal FRACP*†; Quincey, Vicki FRACP*†; Minett, Andrew MBChB; Tam, Gordon MBChB§; Doube, Alan FRACP*; Naden, Ray FRACP

JCR: Journal of Clinical Rheumatology: August 2015 - Volume 21 - Issue 5 - p 239–243
doi: 10.1097/RHU.0000000000000274
Original Articles

Objective In many countries, including New Zealand, the demand for rheumatology services exceeds their supply, resulting in some patients experiencing long delays or being denied access. The principal aim of this work was to create a validated, transparent, and fair system for determining access to rheumatology services.

Methods A panel of 5 rheumatologists, 6 primary care physicians, and 4 nurse specialists ranked a series of 25 clinical scenarios in order of priority to see a rheumatologist. Important determining factors were weighted in an iterative process to generate a multidimensional additive point score to determine access to rheumatology service.

Results The score comprises 6 domains of 2 to 4 items weighted to give a total score out of 100. The effect of the problem on the patient’s life and role, the presence of an inflammatory rheumatic disease, appropriateness of current treatment, and the ability of the rheumatologist to influence the current symptoms and future prognosis were felt to be critical factors in determining access to the service. The score showed a strong correlation with the rankings agreed by the clinical panel, and the overall intraclass correlation coefficient for the rheumatologists was 0.698.

Conclusions Our score has face validity, is easy to perform, and has been assessed by an independent panel of rheumatologists as providing a fair system for determining access to rheumatology services. The system is acceptable to primary care physicians and has been adopted by our local primary care organizations.

From the *Rheumatology Department, Waikato Hospital, Hamilton; †Waikato Clinical School, University of Auckland; ‡Matamata Medical Centre, Matamata; §Midlands Health Network PHO, Hamilton, New Zealand; and ∥McMaster University, Hamilton, Ontario, Canada.

AbbVie, Ltd, supported this work through an unrestricted educational grant, which supported hire of the venue.

The authors declare no conflict of interest.

Correspondence: Douglas White, FRACP, Rheumatology Department, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand. E-mail: douglas.white@waikatodhb.health.nz.

Author Contributions: All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. D.W. and R.N. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study conception and design and acquisition, analysis, and interpretation of data: D.W. and R.N.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.